SBI Life Insurance Company Limited (SBILIFE) — Announcement | 30 July 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
SBI Life reported Q1 FY27 results with double-digit growth in IRP, new business premium, and PAT, reaffirming 14-15% IRP growth guidance.
🔄 What Changed
VNB margin negatively impacted by 60 bps due to shift to lower-margin group business and GTI contracts; non-ULIP product mix improved by 200 bps to 38% of individual APE
🔮 What's Next
14-15% IRP growth guidance reaffirmed; regular pay deferred annuity plan expected next quarter
💡 Investor Takeaway
Shareholders should note near-term margin pressure from product mix shifts but expect recovery as non-ULIP and protection products gain traction.
⚠️ Risks
VNB margin pressure from group business and GTI contracts; GST drag of 1.1 percentage points expected to persist into Q4

SBI Life reported Q1 FY27 results showing 14% YoY IRP growth to INR39.7 billion, 23% YoY new business premium growth to INR89.1 billion, and 22% YoY PAT growth to INR7.2 billion, with 26.2% VoNB margin and 1.96 solvency ratio. Management highlighted agency channel expansion, non-ULIP product mix improvement, and 20.5% private market share as key growth drivers, while noting VNB margin pressure from group business and GTI contracts. The company reaffirmed 14-15% IRP growth guidance and expects margins to recover as product mix normalizes.

📄 View Original Announcement (PDF)

About SBI Life Insurance Company Limited (SBILIFE)

Financial Services · Insurance · Listed on NSE

Market Cap: ₹1,87,026.53 Cr P/E: 75.7

View full SBILIFE stock details →

📡 Get AI alerts when SBILIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SBILIFE — Free

📊 More SBILIFE filings

See all SBILIFE filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SBILIFE files new disclosures

Track SBILIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SBILIFE — Free

Free account · 2 AI queries/day